David Yeung

12PUBLICATIONS
43CO-AUTHORS
ChemotherapyBiologically active moleculesPredictive and prognostic markersTransplantation immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 03, 2025
Medicinal CANnabis (CBD/THC) to prevent the symptoms and side effects of chemotherapy in people with advanced CANcer (CANCAN): protocol for a phase II, randomised, double-blind, placebo-controlled trial.

Olivia M Bellas, Katrina Cao, Joanne Bowen

|Jun 07, 2024
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy.

Laura N Eadie, Elias Lagonik, Elyse C Page

|Aug 24, 2023
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapy.

Ilaria S Pagani, Naranie Shanmuganathan, Phuong Dang

|Jul 31, 2023
Case report: Rare case of donor cell-derived T-cell acute lymphoblastic leukaemia in a female patient after receiving an allo-transplant from her male sibling.

Laura N Eadie, Jacqueline A Rehn, Caitlin E Schutz

|Jul 24, 2023
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.

Yazad D Irani, Amy Hughes, Chung H Kok

|Jan 09, 2023
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia.

Yazad D Irani, Chung H Kok, Jade Clarson

Pageof 2

Frequent Collaborators

6 joint publications

Deborah L White

3 joint publications

Laura N Eadie

3 joint publications

Naranie Shanmuganathan

3 joint publications

Susan Branford